Detail Information of Transcriptional Regulations
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0115 Transporter Info | ||||
| Gene Name | SLC17A2 | ||||
| Transporter Name | Sodium-dependent phosphate transport protein 3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Transcriptional Regulation of This DT (TSR) | ||||||
|---|---|---|---|---|---|---|
|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
|
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Direct binding to SLC17A2 gene | [1] | ||||
|
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
|
Tissue |
Blood; Bone marrow; Breast; Cervix; Colon; Liver; Lung | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
|
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC17A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent phosphate transport protein 3. | |||||
|
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
AR |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Binding to SLC17A2 gene in prostate cancer condition | [2] | ||||
|
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
|
Studied Phenotype |
. | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC17A2 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Sodium-dependent phosphate transport protein 3. | |||||
|
Transcriptional Phenomenon2 |
Binding to SLC17A2 gene | [3] | ||||
|
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC17A2 gene in . condition, which leads to a affected expression of the drug transporter Sodium-dependent phosphate transport protein 3. | |||||
|
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Binding to SLC17A2 gene in health condition | [4] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
|
Studied Phenotype |
. | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC17A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium-dependent phosphate transport protein 3. | |||||
|
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
|
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Binding to SLC17A2 gene in prostate carcinoma condition | [5] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
|
Studied Phenotype |
. | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC17A2 gene in prostate carcinoma condition, which leads to an affected expression of the drug transporter Sodium-dependent phosphate transport protein 3. | |||||
|
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
|
Transcriptional Phenomenon1 |
Binding to SLC17A2 gene in health condition | [4] | ||||
|
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
|
Studied Phenotype |
. | |||||
|
Related DT Changes |
Direct regulating | |||||
|
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC17A2 gene in health condition, which leads to an affected expression of the drug transporter Sodium-dependent phosphate transport protein 3. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.